Albumin-bilirubin grade as an alternative to Child–Pugh class for evaluating liver function within staging systems for hepatocellular carcinoma
Our study confirms comparable or, in some cases, superior prognostic performance of the ALBI grade to the CP class across specific HCC staging systems. ALBI may serve as a complementary or alternative measure that may enhance prognostic accuracy, conducive to therapeutic decisions of oncologists and to the effective management of HCC patients.
Authors
- Ming‐Cheng Guan (ORCID: https://orcid.org/0000-0002-7845-3689)
- Qian Zhao (ORCID: https://orcid.org/0000-0002-9540-5726)
- R Zhang
- Hong Zhu (ORCID: https://orcid.org/0000-0001-7502-278X)
- Na Li (ORCID: https://orcid.org/0000-0002-0392-6672)
- Ji Wang (ORCID: https://orcid.org/0000-0002-2657-9132)
- Shiyu Zhang (ORCID: https://orcid.org/0000-0002-3645-3891)
- Qian Ding (ORCID: https://orcid.org/0000-0002-2301-8487)
Institutions
- Soochow University (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1007/s12672-025-02187-x
- Citations
- 3
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.97
Funders
- National Natural Science Foundation of China